Literature DB >> 20837518

Immunodominant T-cell responses to dengue virus NS3 are associated with DHF.

Thaneeya Duangchinda1, Wanwisa Dejnirattisai, Sirijit Vasanawathana, Wannee Limpitikul, Nattaya Tangthawornchaikul, Prida Malasit, Juthathip Mongkolsapaya, Gavin Screaton.   

Abstract

Dengue infections are increasing at an alarming rate in many tropical and subtropical countries, where epidemics can put health care systems under extreme pressure. The more severe infections lead to dengue hemorrhagic fever (DHF), which can be life threatening. A variety of viral and host factors have been associated with the severity of dengue infections. Because secondary dengue infection is more commonly associated with DHF than primary infections, the acquired immune response to dengue, both B cells and T cells have been implicated. In this study, we set out to study T-cell responses across the entire dengue virus proteome and to see whether these were related to disease severity in a cohort of dengue-infected children from Thailand. Robust responses were observed in most infected individuals against most viral proteins. Responses to NS3 were the most frequent, and there was a very strong association between the magnitude of the response and disease severity. Furthermore, in DHF, cytokine-high CD107a-negative cells predominated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20837518      PMCID: PMC2947904          DOI: 10.1073/pnas.1010867107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  HIV and SIV CTL escape: implications for vaccine design.

Authors:  Philip J R Goulder; David I Watkins
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

Review 2.  Dengue.

Authors:  Scott B Halstead
Journal:  Lancet       Date:  2007-11-10       Impact factor: 79.321

3.  Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes.

Authors:  Hema S Bashyam; Sharone Green; Alan L Rothman
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

Review 4.  A question of self-preservation: immunopathology in influenza virus infection.

Authors:  Nicole L La Gruta; Katherine Kedzierska; John Stambas; Peter C Doherty
Journal:  Immunol Cell Biol       Date:  2007-01-09       Impact factor: 5.126

5.  Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants.

Authors:  S C Kliks; S Nimmanitya; A Nisalak; D S Burke
Journal:  Am J Trop Med Hyg       Date:  1988-03       Impact factor: 2.345

6.  In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody.

Authors:  S B Halstead
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

Review 7.  Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis.

Authors:  Alan L Rothman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

8.  Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations.

Authors:  Natalie E R Beveridge; David A Price; Joseph P Casazza; Ansar A Pathan; Clare R Sander; Tedi E Asher; David R Ambrozak; Melissa L Precopio; Phillip Scheinberg; Nicola C Alder; Mario Roederer; Richard A Koup; Daniel C Douek; Adrian V S Hill; Helen McShane
Journal:  Eur J Immunol       Date:  2007-11       Impact factor: 5.532

9.  Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody.

Authors:  S B Halstead; E J O'Rourke
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

Review 10.  Dengue hemorrhagic fever in infants: research opportunities ignored.

Authors:  Scott B Halstead; Nguyen Trong Lan; Thein Thein Myint; Than Nu Shwe; Ananda Nisalak; Siripen Kalyanarooj; Suchitra Nimmannitya; Soegeng Soegijanto; David W Vaughn; Timothy P Endy
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more
  120 in total

1.  Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.

Authors:  Rosa Ramírez; Rosabel Falcón; Alienys Izquierdo; Angélica García; Mayling Alvarez; Ana Beatriz Pérez; Yudira Soto; Mayra Muné; Emiliana Mandarano da Silva; Oney Ortega; Ronaldo Mohana-Borges; María G Guzmán
Journal:  Virus Genes       Date:  2014-05-23       Impact factor: 2.332

2.  Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques.

Authors:  Katherine M Mladinich; Shari M Piaskowski; Richard Rudersdorf; Christopher M Eernisse; Kim L Weisgrau; Mauricio A Martins; Jessica R Furlott; Charalambos D Partidos; Joseph N Brewoo; Jorge E Osorio; Nancy A Wilson; Eva G Rakasz; David I Watkins
Journal:  Immunogenetics       Date:  2011-09-01       Impact factor: 2.846

Review 3.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

Review 4.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Authors:  Alan L Rothman
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

Review 5.  Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine?

Authors:  Jinsheng Wen; Sujan Shresta
Journal:  Curr Opin Immunol       Date:  2019-03-15       Impact factor: 7.486

6.  Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells.

Authors:  Daniela Weiskopf; Michael A Angelo; Elzinandes L de Azeredo; John Sidney; Jason A Greenbaum; Anira N Fernando; Anne Broadwater; Ravi V Kolla; Aruna D De Silva; Aravinda M de Silva; Kimberly A Mattia; Benjamin J Doranz; Howard M Grey; Sujan Shresta; Bjoern Peters; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-11       Impact factor: 11.205

7.  Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice.

Authors:  Smita Jaiswal; Pamela Pazoles; Marcia Woda; Leonard D Shultz; Dale L Greiner; Michael A Brehm; Anuja Mathew
Journal:  Immunology       Date:  2012-07       Impact factor: 7.397

8.  Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response.

Authors:  James S Testa; Vivekananda Shetty; Gomathinayagam Sinnathamby; Zacharie Nickens; Julie Hafner; Shivali Kamal; Xianchao Zhang; Marti Jett; Ramila Philip
Journal:  J Infect Dis       Date:  2012-01-13       Impact factor: 5.226

Review 9.  Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.

Authors:  Huabin Liang; Min Lee; Xia Jin
Journal:  Cell Mol Immunol       Date:  2015-10-05       Impact factor: 11.530

10.  Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.

Authors:  Laura Rivino; Emmanuelle A P Kumaran; Vojislav Jovanovic; Karen Nadua; En Wei Teo; Shyue Wei Pang; Guo Hui Teo; Victor Chih Hao Gan; David C Lye; Yee Sin Leo; Brendon J Hanson; Kenneth G C Smith; Antonio Bertoletti; David M Kemeny; Paul A MacAry
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.